BDNF and Alzheimer disease: Previous Aβ-infusion models of AD have shown that fingolimod reduces proinflammatory TNF-α and COX-II levels while increasing brain-derived neurotrophic factor (BDNF) [6],Fukumoto et al. 2014a; [32].